OREANDA-NEWS. In recent months, there has been a shortage of drugs for Parkinson's disease in Russian pharmacies. Kommersant writes about this with reference to market participants.

According to the publication, we are talking about drugs based on levodopa, which must be taken daily by 70% of people suffering from parkinsonism (in Russia there are about 300 thousand patients with this diagnosis).

The drugs, which were produced by foreign companies Teva and Hoffmann-La Roche, disappeared from pharmacies last year, since their supplies to Russia were "economically inexpedient." At the end of 2021, the Russian generic of Western drugs, Madopar, left the market.

Participants of the pharmaceutical market told Kommersant that now there are no other analogues of drugs with levodopa in pharmacies. The shortage is caused by broken supply chains of raw materials for medicines.

Last week, the All-Russian Union of Patients asked Prime Minister Mikhail Mishustin to simplify the procedure for registering new drugs. The union proposed to legislate the term "innovative drug" - a medicine that has no analogues in the territory of the EAEU, and to which an accelerated registration procedure can be applied.